← Directory

Noro-Moseley Partners

PE / VC · Atlanta · United States

Address
The Medici Building, 3284 Northside Parkway, Northwest, Suite 525, Atlanta, GA 30327-2337, United States
Email
Website
LinkedIn
Founded
1983
AUM
$600 M
Ticket
$10-50 m

Stages

Series BSeries ALate Stage (Series C+)

Investment region

North AmericaEurope

Industries

HealthTechTechnologyBusiness Services (B2B)Financial ServicesFintechHealthcare ServicesIT ServicesSaaSSoftwareMarketing and AdvertisingMedia and EntertainmentSecurityCybersecurity

Profile

Noro-Moseley Partners is a venture capital firm based in Atlanta, Georgia, established in 1983. The firm was founded by industry veterans with a strong focus on early growth equity for rapidly-scaling B2B technology and healthcare companies. They have built a reputable team that emphasizes partnering with strong CEOs to scale high-growth businesses. The firm's commitment to being more than just investors is evident in their active involvement in strategic decisions. They invest in sectors including business services, healthcare services, and technology, focusing on early growth stages like Series A and B. Noro-Moseley Partners operates primarily within North America. While the exact amount of assets under management is not disclosed, their longstanding industry presence and strategic involvements are well-noted. They are particularly noted for guiding companies through successful exits, having achieved over $5 billion in aggregate enterprise value since 2015. Notable investments include Red Canary - managed detection and response technology, SupplyPike - supply chain visibility software, Contessa Health - comprehensive at-home care, Advance Health - healthcare services, and FSLogix - solutions for desktop virtualization environments. They focus on building sustainable business models and providing strategic board-level advice.

Contacts (2)

NameTitleEmailTéléphoneLinkedIn
Managing General Partner
General Partner

Name, email and phone are partially hidden. Subscribe to see them in full.